Cyclophosphamide and platelet count decreased Patient Reports February 11, 2012

Cyclophosphamide Side Effects Report #5852218-9
Cyclophosphamide side effect was reported by a Health Professional from SWEDEN on Aug 19, 2008. Male patient, 44 years of age, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: haemoglobin decreased, heart rate increased, hyperhidrosis, nausea , neutropenia, oedema peripheral, oxygen saturation decreased, platelet count decreased, pleural effusion. Cyclophosphamide dosage: unknown. During the same period patient was treated with FLUDARABINE, RITUXAN. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5742920-1
Cyclophosphamide side effect was reported by a Pharmacist from UNITED STATES on May 15, 2008. Male patient, weighting 44.75 lb, was diagnosed with neuroblastoma  and was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: haematuria, haemoglobin decreased, haemorrhage urinary tract, pain , platelet count decreased, thrombosis. Cyclophosphamide dosage: 180 MG X41 IV. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #4893506-2
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 25, 2006. Male patient, weighting 205.0 lb, was diagnosed with multiple myeloma  and was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased, white blood cell count decreased, white blood cell count increased. Cyclophosphamide dosage: unknown. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #4886085-7
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2006. Male patient, weighting 185.2 lb, was diagnosed with haematopoietic neoplasm and was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: catheter site cellulitis, haemoglobin decreased, neutrophil count decreased, platelet count decreased, skin infection, white blood cell count decreased. Cyclophosphamide dosage: unknown. Patient was hospitalized. Patient recovered.


Cyclophosphamide Side Effects Report #5001692-9
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on May 12, 2006. Male patient, weighting 188.9 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: haemoglobin decreased, haemolysis, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Cyclophosphamide dosage: 795 MG. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #4918470-9
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 17, 2006. Male patient, weighting 183.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: aspergillosis, computerised tomogram abnormal, eye haemorrhage, febrile neutropenia, haemoglobin decreased, lymphadenopathy, platelet count decreased, pneumonia fungal. Cyclophosphamide dosage: 600 MG. During the same period patient was treated with PENTOSTATIN. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #4552832-7
Cyclophosphamide side effect was reported by a Health Professional from on Oct 04, 2004. Female patient, 57 years of age, weighting 255.7 lb, was diagnosed with breast cancer  and was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: cough, dyspnoea, haematocrit decreased, lung consolidation, lymphoedema, neutropenia, palpitations, platelet count decreased, pyrexia. Cyclophosphamide dosage: unknown. During the same period patient was treated with PACLITAXEL, EPIRUBICIN, GEMCITABINE, FUROSEMIDE, LANSOPRAZOLE, BISOPROLOL FUMARATE, CANDESARTAN. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #4862835-0
Cyclophosphamide side effect was reported by a Health Professional from GERMANY on Sept 20, 2005. Female patient, 51 years of age, weighting 196.2 lb, was diagnosed with breast cancer  and was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: haemoglobin decreased, iiird nerve paralysis, platelet count decreased, white blood cell count decreased. Cyclophosphamide dosage: unknown. During the same period patient was treated with TAXOL, EPIRUBICIN, NEORECORMON, GRANOCYTE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #4850535-2
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 08, 2005. Female patient, weighting 209.4 lb, was diagnosed with breast cancer  and was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Cyclophosphamide dosage: unknown. During the same period patient was treated with DOXORUBICIN. Patient recovered.


Cyclophosphamide Side Effects Report #4863276-2
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 19, 2005. Female patient, weighting 209.4 lb, was diagnosed with breast cancer  and was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, platelet count decreased, pyrexia, white blood cell count decreased. Cyclophosphamide dosage: unknown. During the same period patient was treated with DOXORUBICIN. Patient recovered.

Cyclophosphamide Side Effects Report #4877477-0
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 09, 2006. Female patient, weighting 99.21 lb, was diagnosed with breast cancer  and was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: anaemia, platelet count decreased. Cyclophosphamide dosage: unknown. During the same period patient was treated with DOXORUBICIN. Patient recovered.

Cyclophosphamide Side Effects Report #4991437-0
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on May 02, 2006. Female patient, weighting 136.2 lb, was diagnosed with breast cancer  and was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: chromaturia, culture urine positive, escherichia infection, haemoglobin decreased, platelet count decreased, pyrexia, urine abnormality, white blood cell count decreased. Cyclophosphamide dosage: 1000 MG. During the same period patient was treated with DOXORUBICIN. Patient recovered.

Cyclophosphamide Side Effects Report #5019915-9
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2006. Female patient, weighting 200.4 lb, was diagnosed with breast cancer  and was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: anaemia, fatigue, gastritis, gastrointestinal haemorrhage, haemorrhoids, platelet count decreased, rectal polyp, thrombosis. Cyclophosphamide dosage: 1200 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #4950791-6
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 21, 2006. Male patient, 67 years of age, weighting 158.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased, platelet disorder, pyrexia, tremor. Cyclophosphamide dosage: 1800 MG. During the same period patient was treated with CYTARABINE, DEXAMETHASONE, ELSPAR, METHOTREXATE, BACTRIM DS. Patient was hospitalized. Patient recovered.


Cyclophosphamide Side Effects Report #5241578-8
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 12, 2007. Female patient, weighting 122.1 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood culture positive, catheter related infection, herpes zoster disseminated, intestinal ischaemia, neutropenic colitis, platelet count decreased, pseudomembranous colitis. Cyclophosphamide dosage: 1520 MG. During the same period patient was treated with CYTARABINE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #4786921-9
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 30, 2005. Male patient, weighting 132.3 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: neutropenia, platelet count decreased. Cyclophosphamide dosage: unknown. During the same period patient was treated with ALLOPURINOL, DAUNORUBICIN, VINCRISTINE, DEXAMETHASONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5589417-X
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2008. Male patient, 73 years of age, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: epistaxis, petechiae, platelet count decreased. Cyclophosphamide dosage: unknown. During the same period patient was treated with ASPIRIN, LISINOPRIL, ATENOLOL, FLUDARA, AMLODIPINE, ATORVASTATIN. Patient was hospitalized and became disabled. Patient recovered.

Cyclophosphamide Side Effects Report #5096860-4
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 31, 2006. Female patient, 62 years of age, weighting 147.5 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: blood potassium decreased, haemoglobin decreased, headache , neutropenia, platelet count decreased, pyrexia, white blood cell count decreased. Cyclophosphamide dosage: 1044 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5330396-8
Cyclophosphamide side effect was reported by a Consumer or non-health professional from on May 15, 2007. Female patient, 59 years of age, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: anaemia macrocytic, chromosome abnormality, chronic myelomonocytic leukaemia, cushingoid, pallor, platelet count decreased, thrombocytopenia. Cyclophosphamide dosage: unknown. During the same period patient was treated with PREDNISONE. Patient recovered.


Cyclophosphamide Side Effects Report #5329896-6
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2007. Female patient, weighting 133.3 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: fatigue, febrile neutropenia, granulocyte count decreased, platelet count decreased, white blood cell count decreased. Cyclophosphamide dosage: 966 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5344210-8
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on May 31, 2007. Female patient, weighting 133.3 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: febrile neutropenia, platelet count decreased, urinary tract disorder. Cyclophosphamide dosage: 966 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5080660-5
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 14, 2006. Male patient, weighting 179.7 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Cyclophosphamide dosage: 2400 MG. During the same period patient was treated with DAUNORUBICIN, DEXAMETHASONE, ELSPAR, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5087850-6
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 21, 2006. Female patient, weighting 222.4 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: abdominal pain , dyspnoea, neutrophil count decreased, pain in extremity, platelet count decreased, respiratory rate increased, vomiting, white blood cell count decreased. Cyclophosphamide dosage: 1530 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient died on 08/10/2006.

Cyclophosphamide Side Effects Report #5132303-X
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 20, 2006. Male patient, weighting 208.4 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: abdominal pain , dehydration, febrile neutropenia, intestinal obstruction, nausea , platelet count decreased. Cyclophosphamide dosage: 1650 MG; IV INFUSION DAY 5 ONLY PER PROTOCOL. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.


Cyclophosphamide Side Effects Report #5158173-1
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 20, 2006. Female patient, weighting 132.3 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: hepatic steatosis, hepatitis acute, hepatocellular damage, liver transplant , platelet count decreased. Cyclophosphamide dosage: 2400 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5162373-4
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 27, 2006. Male patient, weighting 135.8 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: haemoglobin decreased, mucosal inflammation, neutrophil count abnormal, oral intake reduced, platelet count decreased, white blood cell count decreased. Cyclophosphamide dosage: 5400 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, LEUCOVORIN CALCIUM, METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5389348-4
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2007. Female patient, weighting 128.1 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: neutrophil count decreased, platelet count decreased, white blood cell count decreased. Cyclophosphamide dosage: 950 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient recovered.

Cyclophosphamide Side Effects Report #5389350-2
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2007. Female patient, weighting 127.2 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Cyclophosphamide dosage: 950 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient recovered.

Cyclophosphamide Side Effects Report #5389370-8
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2007. Female patient, weighting 126.8 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Cyclophosphamide dosage: 950 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient recovered.


Cyclophosphamide Side Effects Report #5400127-1
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2007. Male patient, weighting 231.5 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: lobar pneumonia, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Cyclophosphamide dosage: 1750 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5411958-6
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 10, 2007. Female patient, weighting 123.0 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Cyclophosphamide dosage: 950 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient recovered.

Cyclophosphamide Side Effects Report #5429300-3
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 27, 2007. Male patient, weighting 194.0 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: platelet count decreased, white blood cell count decreased. Cyclophosphamide dosage: 1224 MG. During the same period patient was treated with DOXIL, NEULASTA, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE, ATENOLOL, CENTRUM, DOXAZOSIN MESYLATE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5580488-3
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 31, 2007. Female patient, weighting 124.3 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: bacterial infection , febrile neutropenia, platelet count decreased. Cyclophosphamide dosage: 3720 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5591126-8
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 10, 2008. Female patient, weighting 166.0 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: blood pressure increased, haemoglobin decreased, neutrophil count decreased, platelet count decreased, pseudomonas infection. Cyclophosphamide dosage: 3200 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, LEUCOVORIN CALCIUM, MESNA, METHOTREXATE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.


Cyclophosphamide Side Effects Report #5625554-9
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 11, 2008. Female patient, weighting 132.3 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: haemoglobin decreased, headache , oedema peripheral, pharyngolaryngeal pain, platelet count decreased, pyrexia, white blood cell count decreased. Cyclophosphamide dosage: 1262 MG. During the same period patient was treated with DOXIL, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5672510-0
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 18, 2008. Female patient, weighting 123.5 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: neutrophil count decreased, platelet count decreased, pyrexia, white blood cell count decreased. Cyclophosphamide dosage: 912 MG. During the same period patient was treated with DOXIL, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5758700-7
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on June 03, 2008. Male patient, weighting 138.2 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, heart rate increased, mucosal inflammation, pharyngolaryngeal pain, platelet count decreased, stomatitis. Cyclophosphamide dosage: 2799 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5789203-1
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on June 25, 2008. Male patient, weighting 155.9 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: catheter site cellulitis, febrile neutropenia, platelet count decreased, white blood cell count decreased. Cyclophosphamide dosage: 4980 MG. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5833759-7
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 04, 2008. Male patient, weighting 196.9 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased. Cyclophosphamide dosage: 1240 MG. During the same period patient was treated with PENTOSTATIN, RITUXIMAB. Patient recovered.


Cyclophosphamide Side Effects Report #5856826-0
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 22, 2008. Male patient, weighting 158.7 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: anaemia, platelet count decreased. Cyclophosphamide dosage: 1567 MG. During the same period patient was treated with CYTARABINE, DOXIL, PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5956936-3
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 17, 2008. Male patient, weighting 183.0 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: cough, haemoglobin decreased, lung infiltration, neutrophil count decreased, platelet count decreased, pyrexia, white blood cell count decreased. Cyclophosphamide dosage: 1500 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #6018964-1
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 21, 2008. Male patient, weighting 164.7 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: constipation , diarrhoea, haemoglobin decreased, neutrophil count decreased, platelet count decreased, syncope. Cyclophosphamide dosage: 1463 MG. During the same period patient was treated with DOXIL, NEULASTA, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE, LEXAPRO, LIPITOR, VITIMAN. Patient recovered.

Cyclophosphamide Side Effects Report #6067242-3
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 04, 2009. Female patient, weighting 101.2 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood pressure diastolic decreased, febrile neutropenia, laryngitis, pharyngitis, platelet count decreased, viral infection , white blood cell count decreased. Cyclophosphamide dosage: 920 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, FOSAMAX. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5035296-9
Cyclophosphamide side effect was reported by a Consumer or non-health professional from UNITED STATES on June 22, 2006. Male patient, weighting 188.9 lb, was treated with Cyclophosphamide. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemolytic anaemia, platelet count decreased, white blood cell count decreased. Cyclophosphamide dosage: 795 MG. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.